John L. Lubniewski, Chief Business Officer at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 6,889 shares at $2.36 ($16K) on 2016-03-11, disclosed to the SEC on 2016-03-14.
Scheduled sale ($16k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.49 | 1,512 | $4K | 22.9% |
| 2 | $2.36 | 5,264 | $12K | 75.6% |
| 3 | $2.19 | 113 | $247 | 1.5% |
| Total | $2.39 avg | 6,889 | $16K | 100% |
| Filing → |
| HTGM | BUY | 2015-08-12 | $38K | — | Filing → |